Enanta Pharmaceuticals Inc

-2.17 (-4.93%)
Earnings Announcements

Enanta Pharmaceuticals Q2 Loss Per Share $1.63

Published: 05/09/2022 21:17 GMT
Enanta Pharmaceuticals Inc (ENTA) - Q2 Loss per Share $1.63.
Royalty Revenue for Quarter Was $18.7 Million.
Enanta - Sees Current Cash, Cash Equivalents, Marketable Securities, to Be Sufficient to Meet Cash Requirements of Existing Programs for at Least Next 2 Yrs.
Q2 Earnings per Share View $-1.43 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $20.16 Million
Adjusted EPS is expected to be -$1.42

Next Quarter Revenue Guidance is expected to be $22.68 Million
Next Quarter EPS Guidance is expected to be -$1.28

More details on our Analysts Page.